Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Bioventures 2014 L.P. Mpm sold 57,225 shares of the company’s stock in a transaction on Wednesday, December 3rd. The shares were sold at an average price of $0.87, for a total value of $49,785.75. Following the sale, the insider directly owned 4,867,341 shares of the […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Bioventures 2014 L.P. Mpm sold 59,277 shares of the stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $0.89, for a total value of $52,756.53. Following the transaction, the insider owned 4,924,566 shares in the company, valued […]

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) insider Andrew Hollman Meyer sold 3,333 shares of the firm’s stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $32.98, for a total value of $109,922.34. Following the transaction, the insider directly owned 84,974 shares in the company, valued […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Ansbert Gadicke sold 60,917 shares of the stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $0.94, for a total transaction of $57,261.98. Following the completion of the sale, the insider directly owned 4,983,843 shares […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Ansbert Gadicke sold 20,277 shares of the business’s stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $0.99, for a total value of $20,074.23. Following the completion of the transaction, the insider owned 5,044,760 shares in the […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Ansbert Gadicke sold 60,733 shares of the firm’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $0.98, for a total value of $59,518.34. Following the completion of the sale, the insider directly owned 5,065,037 shares in […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 27,297 shares of the company’s stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $0.92, for a total transaction of $25,113.24. Following the completion of the transaction, the director owned 3,287,551 shares of the company’s […]

Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) major shareholder Ansbert Gadicke sold 64,331 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $0.83, for a total value of $53,394.73. Following the sale, the insider owned 5,257,105 shares in the company, valued at […]